Towards an estimate of the prevalence of lymphoedema in Australia
Citation
AIHW
Australian Institute of Health and Welfare (2023) Towards an estimate of the prevalence of lymphoedema in Australia , AIHW, Australian Government, accessed 20 May 2024.
APA
Australian Institute of Health and Welfare. (2023). Towards an estimate of the prevalence of lymphoedema in Australia . Canberra: AIHW.
MLA
Australian Institute of Health and Welfare. Towards an estimate of the prevalence of lymphoedema in Australia . AIHW, 2023.
Vancouver
Australian Institute of Health and Welfare. Towards an estimate of the prevalence of lymphoedema in Australia . Canberra: AIHW; 2023.
Harvard
Australian Institute of Health and Welfare 2023, Towards an estimate of the prevalence of lymphoedema in Australia , AIHW, Canberra.
PDF | 1.3Mb
Lymphoedema is a condition where the accumulation of excessive amounts of protein-rich fluid in the tissue results in swelling of one or more regions of the body. The purpose of this scoping study is to assess the utility of available data sources in determining an estimate of the number of Australian’s living with lymphoedema. This report provides the basis for future analytical reports describing the prevalence of lymphoedema.
- Cat. no: PHE 325
- Pages: 45
-
Lymphoedema is a chronic, progressive condition that left unmanaged will cause increasing morbidity for the individual
-
There is currently no population-level estimate for the number of people in Australia living with lymphoedema
-
There were 9,400 hospitalisations for lymphoedema in 2021 – 6,500 for females and 2,900 for males
-
The Australian Cancer Database is a useful data source for predicting the prevalence of cancer-related lymphoedema